Metabolomics Network Analysis of Various Genotypes Associated with Schizophrenia Gene Variant

Area of Science:

• Genetics
• Metabolomics
• Neuroscience

Background:

• Investigates metabolic perturbations in serum samples linked to the schizophrenia susceptibility gene NOS1AP-rs12742393.
• Examines different genotypes (AA, AC, CC) of the NOS1AP-rs12742393 polymorphism.

Purpose of the Study:

• To identify and characterize metabolic alterations associated with specific NOS1AP-rs12742393 genotypes.
• To explore the role of serum metabolomics in understanding genetic contributions to schizophrenia.

Main Methods:

• Utilized publicly available serum metabolomics datasets.
• Employed ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS) for metabolite profiling.
• Applied network and enrichment analyses to identify genotype-associated metabolic patterns.

Main Results:

• Identified key metabolites including tryptophan, 2-aminobutyric acid, palmitic acid, and 5-hydroxytryptophan linked to NOS1AP-rs12742393 genotypes AA-AC and AA.
• Enrichment analysis revealed distinct metabolite sets differentially distributed across genotypes, particularly in genotype AA.
• Highlighted significant associations between specific metabolites and NOS1AP-rs12742393 genotypes.

Conclusions:

• NOS1AP-rs12742393 influences complex metabolic alterations involving amino acids, organic compounds, fatty acids, and cholic acids.
• Serum metabolome analysis is sensitive and specific for revealing genotype-associated metabolic profiles.
• Supports a network-based approach for understanding schizophrenia susceptibility and its genetic underpinnings.